메뉴 건너뛰기




Volumn 4, Issue 5, 2013, Pages 593-614

Strategies for enhanced peptide and protein delivery

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ATORVASTATIN; CALCITONIN; CARBOPOL 974P; CHITOSAN; ELCATONIN; EXOPEPTIDASE; GLYCODEOXYCHOLIC ACID; GONADORELIN; HEXYL INSULIN MONOCONJUGATE 2; HUMAN GROWTH HORMONE; INSULIN; LEVONORGESTREL; MACROGOL; NANOPARTICLE; PENETRATION ENHANCING AGENT; POLOXAMER; POLYSTYRENE; PROTEINASE; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

EID: 84877681516     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.13.31     Document Type: Review
Times cited : (30)

References (176)
  • 1
    • 0018369605 scopus 로고
    • Expression in Escherichia coli of chemically synthesized genes for human insulin
    • Goeddel DV, Kleid DG, Bolivar F et al. Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc. Natl Acad. Sci. USA 76(1), 106-110 (1979
    • (1979) Proc. Natl Acad. Sci. USA , vol.76 , Issue.1 , pp. 106-110
    • Goeddel, D.V.1    Kleid, D.G.2    Bolivar, F.3
  • 2
    • 54049101216 scopus 로고    scopus 로고
    • Drug discovery: Past, present and future
    • Malik NN. Drug discovery: past, present and future. Drug Discov. Today. 13(21-22), 909-912 (2008
    • (2008) Drug Discov. Today , vol.13 , Issue.21-22 , pp. 909-912
    • Malik, N.N.1
  • 3
    • 84857459290 scopus 로고    scopus 로고
    • Pharmaceutical Research Manufacturers Association Pharmaceutical Research And Manufacturers Association Washington DC, USA
    • Pharmaceutical Research and Manufacturers Association. Biotechnology Medicines in Development. Pharmaceutical Research and Manufacturers Association, Washington, DC, USA (2011
    • (2011) Biotechnology Medicines in Development
  • 4
    • 84877667086 scopus 로고    scopus 로고
    • Protein structure, purification and characterisation
    • Wilson K, Walker J (Eds Cambridge, University Press, Cambridge, UK
    • Walker J. Protein structure, purification and characterisation. In: Practical Biochemistry Principals and Techniques. Wilson K, Walker J (Eds). Cambridge University Press, Cambridge, UK (2000
    • (2000) Practical Biochemistry Principals and Techniques
    • Walker, J.1
  • 7
    • 84871380139 scopus 로고    scopus 로고
    • Prospects in the total synthesis of protein therapeutics
    • Chalker JM. Prospects in the total synthesis of protein therapeutics. Chem. Biol. Drug Des. 81(1), 122-135 (2013
    • (2013) Chem. Biol. Drug des , vol.81 , Issue.1 , pp. 122-135
    • Chalker, J.M.1
  • 8
    • 79955632991 scopus 로고    scopus 로고
    • Longer action means better drug: Tuning up protein therapeutics
    • Szlachcic A, Zakrzewska M, Otlewski J. Longer action means better drug: tuning up protein therapeutics. Biotechnol. Adv. 29(4), 436-441 (2011
    • (2011) Biotechnol. Adv , vol.29 , Issue.4 , pp. 436-441
    • Szlachcic, A.1    Zakrzewska, M.2    Otlewski, J.3
  • 9
    • 0024806396 scopus 로고
    • Stability of protein pharmaceuticals
    • Manning MC, Patel K, Borchardt RT. Stability of protein pharmaceuticals. Pharm. Res. 6(11), 903-918 (1989
    • (1989) Pharm. Res , vol.6 , Issue.11 , pp. 903-918
    • Manning, M.C.1    Patel, K.2    Borchardt, R.T.3
  • 11
    • 52449102139 scopus 로고    scopus 로고
    • Past, present, and future technologies for oral delivery of therapeutic proteins
    • Singh R, Singh S, Lillard JW Jr. Past, present, and future technologies for oral delivery of therapeutic proteins. J. Pharm. Sci. 97 (7), 2497-2523 (2008
    • (2008) J. Pharm. Sci , vol.97 , Issue.7 , pp. 2497-2523
    • Singh, R.1    Singh, S.2    Lillard Jr., J.W.3
  • 12
    • 40749145377 scopus 로고    scopus 로고
    • Properties and formulation of oral drug delivery systems of protein and peptides
    • Semalty A, Semalty M, Singh R, Saraf SK, Saraf S. Properties and formulation of oral drug delivery systems of protein and peptides. Indian J. Pharm. Sci. 69, 741-747 (2007
    • (2007) Indian J. Pharm. Sci , vol.69 , pp. 741-747
    • Semalty, A.1    Semalty, M.2    Singh, R.3    Saraf, S.K.4    Saraf, S.5
  • 13
    • 34548222649 scopus 로고    scopus 로고
    • Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges
    • Lundy FT, Nelson J, Lockhart D, Greer B, Harriott P, Marley JJ. Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges. Mol. Immunol. 45(1), 190-193 (2008
    • (2008) Mol. Immunol , vol.45 , Issue.1 , pp. 190-193
    • Lundy, F.T.1    Nelson, J.2    Lockhart, D.3    Greer, B.4    Harriott, P.5    Marley, J.J.6
  • 14
    • 77951498805 scopus 로고    scopus 로고
    • Protein aggregation-pathways and inf luencing factors
    • Wang W, Nema S, Teagarden D. Protein aggregation-pathways and inf luencing factors. Int. J. Pharm. 390(2), 89-99 (2010
    • (2010) Int. J. Pharm , vol.390 , Issue.2 , pp. 89-99
    • Wang, W.1    Nema, S.2    Teagarden, D.3
  • 15
    • 63749128279 scopus 로고    scopus 로고
    • Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeutics
    • De Groot AS, Martin W. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clin. Immunol. 131(2), 189-201 (2009
    • (2009) Clin. Immunol , vol.131 , Issue.2 , pp. 189-201
    • De Groot, A.S.1    Martin, W.2
  • 16
    • 69249203868 scopus 로고    scopus 로고
    • Immunogenicity assessment of therapeutic proteins and peptides
    • Kaliyaperumal A, Jing S. Immunogenicity assessment of therapeutic proteins and peptides. Curr. Pharm. Biotechnol. 10(4), 352-358 (2009
    • (2009) Curr. Pharm. Biotechnol , vol.10 , Issue.4 , pp. 352-358
    • Kaliyaperumal, A.1    Jing, S.2
  • 17
    • 77958483948 scopus 로고    scopus 로고
    • Pre-clinical considerations in the assessment of immunogenicity for protein therapeutics
    • Baker M, Carr F. Pre-clinical considerations in the assessment of immunogenicity for protein therapeutics. Curr. Drug Saf. 5(4), 308-313 (2010
    • (2010) Curr. Drug Saf , vol.5 , Issue.4 , pp. 308-313
    • Baker, M.1    Carr, F.2
  • 18
    • 84868576131 scopus 로고    scopus 로고
    • Clinical pharmacology considerations in biologics development
    • Zhao L, Ren TH, Wang DD. Clinical pharmacology considerations in biologics development. Acta Pharmacol. Sin. 33(11), 1339-1347 (2012
    • (2012) Acta Pharmacol. Sin , vol.33 , Issue.11 , pp. 1339-1347
    • Zhao, L.1    Ren, T.H.2    Wang, D.D.3
  • 19
    • 84866735537 scopus 로고    scopus 로고
    • Pharmacokinetic considerations for antibody drug conjugates
    • Lin K, Tibbitts J. Pharmacokinetic considerations for antibody drug conjugates. Pharm. Res. 29(9), 2354-2366 (2012
    • (2012) Pharm. Res , vol.29 , Issue.9 , pp. 2354-2366
    • Lin, K.1    Tibbitts, J.2
  • 20
    • 18644361997 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
    • Mahmood I, Green M. Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins. Clin. Pharmacokinet. 44(4), 331-347 (2005
    • (2005) Clin. Pharmacokinet , vol.44 , Issue.4 , pp. 331-347
    • Mahmood, I.1    Green, M.2
  • 21
    • 85047692219 scopus 로고
    • Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism
    • Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82(10), 979-987 (1993
    • (1993) J. Pharm. Sci , vol.82 , Issue.10 , pp. 979-987
    • Aungst, B.J.1
  • 22
    • 84871679525 scopus 로고    scopus 로고
    • Peptide Drug Discovery and Development: Translational Research in Academia and Industry Castanho M, Santos NC (Eds). Wiley-VCH, NJ, USA
    • Hamman JH, Steenekamp JH. Oral peptide drug delivery: strategies to overcome challenges. In: Peptide Drug Discovery and Development: Translational Research in Academia and Industry. Castanho M, Santos NC (Eds). Wiley-VCH, NJ, USA (2011
    • (2011) Oral Peptide Drug Delivery: Strategies to Overcome Challenges
    • Hamman, J.H.1    Steenekamp, J.H.2
  • 23
    • 4344634877 scopus 로고    scopus 로고
    • Pharmacokinetic aspects of biotechnology products
    • Tang L, Persky AM, Hochhaus G, Meibohm B. Pharmacokinetic aspects of biotechnology products. J. Pharm. Sci. 93(9), 2184-2204 (2004
    • (2004) J. Pharm. Sci , vol.93 , Issue.9 , pp. 2184-2204
    • Tang, L.1    Persky, A.M.2    Hochhaus, G.3    Meibohm, B.4
  • 26
    • 34547899919 scopus 로고    scopus 로고
    • Solid lipid nanoparticles as a drug delivery system for peptides and proteins
    • Almeida A, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv. Drug Deliver. Rev. 59, 478-490 (2007
    • (2007) Adv. Drug Deliver. Rev , vol.59 , pp. 478-490
    • Almeida, A.1    Souto, E.2
  • 28
    • 33746872198 scopus 로고    scopus 로고
    • Novel delivery technologies for protein and peptide therapeutics
    • Kumar TR, Soppimath K, Nachaegari SK. Novel delivery technologies for protein and peptide therapeutics. Curr. Pharm. Biotechnol. 7(4), 261-276 (2006
    • (2006) Curr. Pharm. Biotechnol , vol.7 , Issue.4 , pp. 261-276
    • Kumar, T.R.1    Soppimath, K.2    Nachaegari, S.K.3
  • 29
    • 22244488749 scopus 로고    scopus 로고
    • Oral delivery of peptide drugs: Barriers and developments
    • Hamman JH, Enslin GM, Kotzé AF. Oral delivery of peptide drugs: barriers and developments. Bio. Drugs 19, 165-177 (2005
    • (2005) Bio. Drugs , vol.19 , pp. 165-177
    • Hamman, J.H.1    Enslin, G.M.2    Kotzé, A.F.3
  • 30
    • 84871436009 scopus 로고    scopus 로고
    • Paracellular drug absorption enhancement through tight junction modulation
    • Lemmer HJ, Hamman JH. Paracellular drug absorption enhancement through tight junction modulation. Expert Opin. Drug Deliv. 10(1), 103-114 (2013
    • (2013) Expert Opin. Drug Deliv , vol.10 , Issue.1 , pp. 103-114
    • Lemmer, H.J.1    Hamman, J.H.2
  • 31
    • 33746790243 scopus 로고    scopus 로고
    • Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin
    • Motlekar NA, Fasano A, Wachtel MS, Youan BB. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin. J. Drug Target. 14(5), 321-329 (2006
    • (2006) J. Drug Target , vol.14 , Issue.5 , pp. 321-329
    • Motlekar, N.A.1    Fasano, A.2    Wachtel, M.S.3    Youan, B.B.4
  • 32
    • 0037027876 scopus 로고    scopus 로고
    • Bioadhesive polysaccharide in protein delivery system: Chitosan nanoparticles improve the intestinal absorption of insulin in vivo
    • Pan Y. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm. 249, 139-147 (2002
    • (2002) Int. J. Pharm , vol.249 , pp. 139-147
    • Pan, Y.1
  • 33
    • 0033020555 scopus 로고    scopus 로고
    • Polymers with thiol groups: A new generation of mucoadhesive polymers?
    • Bernkop-Schnürch A, Schwarz V, Steininger S. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm. Res. 16(6), 876-881 (1999
    • (1999) Pharm. Res , vol.16 , Issue.6 , pp. 876-881
    • Bernkop-Schnürch, A.1    Schwarz, V.2    Steininger, S.3
  • 34
    • 26644452975 scopus 로고    scopus 로고
    • Thiomers: A new generation of mucoadhesive polymers
    • Bernkop-Schnürch A. Thiomers: a new generation of mucoadhesive polymers. Adv. Drug Deliv. Rev. 57(11), 1569-1582 (2005
    • (2005) Adv. Drug Deliv. Rev , vol.57 , Issue.11 , pp. 1569-1582
    • Bernkop-Schnürch, A.1
  • 35
    • 0029121427 scopus 로고
    • Penetration enhancement effect of Pz-peptide, a paracellularly transported peptide, in rabbit intestinal segments and Caco-2 cell monolayers
    • Yen WC, Lee VH. Penetration enhancement effect of Pz-peptide, a paracellularly transported peptide, in rabbit intestinal segments and Caco-2 cell monolayers. J. Control. Release 36, 25-37 (1995
    • (1995) J. Control. Release , vol.36 , pp. 25-37
    • Yen, W.C.1    Lee, V.H.2
  • 36
    • 33646492929 scopus 로고    scopus 로고
    • Tight junction modulation and its relationship to drug delivery
    • Salama NN, Eddington ND, Fasano A. Tight junction modulation and its relationship to drug delivery. Adv. Drug Deliv. Rev. 58, 15-28 (2006
    • (2006) Adv. Drug Deliv. Rev , vol.58 , pp. 15-28
    • Salama, N.N.1    Eddington, N.D.2    Fasano, A.3
  • 38
    • 75149183678 scopus 로고    scopus 로고
    • Glycosylation of therapeutic proteins: An effective strategy to optimize efficacy
    • Solá RJ, Griebenow K. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 24(1), 9-21 (2010
    • (2010) BioDrugs , vol.24 , Issue.1 , pp. 9-21
    • Solá, R.J.1    Griebenow, K.2
  • 39
    • 84857582436 scopus 로고    scopus 로고
    • PEGylation of proteins and liposomes: A powerful and flexible strategy to improve the drug delivery
    • Milla P, Dosio F, Cattel L. PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr. Drug Metab. 13(1), 105-119 (2012
    • (2012) Curr. Drug Metab , vol.13 , Issue.1 , pp. 105-119
    • Milla, P.1    Dosio, F.2    Cattel, L.3
  • 40
    • 77954537092 scopus 로고    scopus 로고
    • Acyl modified chitosan derivatives for oral delivery of insulin and curcumin
    • Shelma R, Sharma CP. Acyl modified chitosan derivatives for oral delivery of insulin and curcumin. J. Mater. Sci. Mater. Med. 21(7), 2133-2140 (2010
    • (2010) J. Mater. Sci. Mater. Med , vol.21 , Issue.7 , pp. 2133-2140
    • Shelma, R.1    Sharma, C.P.2
  • 41
    • 0034617463 scopus 로고    scopus 로고
    • Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein
    • Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. 476(3), 258-261 (2000
    • (2000) FEBS Lett , vol.476 , Issue.3 , pp. 258-261
    • Fujita, K.1    Katahira, J.2    Horiguchi, Y.3    Sonoda, N.4    Furuse, M.5    Tsukita, S.6
  • 42
    • 84855935214 scopus 로고    scopus 로고
    • The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier
    • Rosenthal R, Günzel D, Finger C et al. The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier. Biomaterials 33(9), 2791-2800 (2012
    • (2012) Biomaterials , vol.33 , Issue.9 , pp. 2791-2800
    • Rosenthal, R.1    Günzel, D.2    Finger, C.3
  • 43
    • 54549097056 scopus 로고    scopus 로고
    • Conjugated chitosan as a novel platform for oral delivery of paclitaxel
    • Lee E, Lee J, Lee IH et al. Conjugated chitosan as a novel platform for oral delivery of paclitaxel. J. Med. Chem. 51(20), 6442-6449 (2008
    • (2008) J. Med. Chem , vol.51 , Issue.20 , pp. 6442-6449
    • Lee, E.1    Lee, J.2    Lee, I.H.3
  • 44
    • 85157101793 scopus 로고    scopus 로고
    • Oral drug delivery systems using chemical conjugates or physical complexes
    • doi:10.1016/j.addr.11.002 Epub ahead of print
    • Al-Hilal TA, Alam F, Byun Y. Oral drug delivery systems using chemical conjugates or physical complexes. Adv. Drug Deliv. Rev. doi:10.1016/j.addr.11. 002 (2012) (Epub ahead of print
    • (2012) Adv. Drug Deliv. Rev
    • Al-Hilal, T.A.1    Alam, F.2    Byun, Y.3
  • 46
    • 81255156925 scopus 로고    scopus 로고
    • Oral delivery of macromolecules: Rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET
    • Walsh EG, Adamczyk BE, Chalasani KB et al. Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET). Ther. Deliv. 2(12), 1595-1610 (2011
    • (2011) Ther. Deliv , vol.2 , Issue.12 , pp. 1595-1610
    • Walsh, E.G.1    Adamczyk, B.E.2    Chalasani, K.B.3
  • 47
    • 80053905149 scopus 로고    scopus 로고
    • Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats
    • Anwar M, Warsi MH, Mallick N et al. Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats. Eur. J. Pharm. Sci. 44(3), 241-249 (2011
    • (2011) Eur. J. Pharm. Sci , vol.44 , Issue.3 , pp. 241-249
    • Anwar, M.1    Warsi, M.H.2    Mallick, N.3
  • 48
    • 0021236615 scopus 로고
    • An in vitro investigation of mucosa-adhesive materials for use in controlled drug delivery
    • Smart JD, Kellaway IW, Worthington HE. An in vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol. 36(5), 295-299 (1984
    • (1984) J. Pharm. Pharmacol , vol.36 , Issue.5 , pp. 295-299
    • Smart, J.D.1    Kellaway, I.W.2    Worthington, H.E.3
  • 51
    • 0026802436 scopus 로고
    • The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region
    • Gum JR Jr, Hicks JW, Toribara NW, Rothe EM, Lagace RE, Kim YS. The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region. J. Biol. Chem. 267(30), 21375-21383 (1992
    • (1992) J. Biol. Chem , vol.267 , Issue.30 , pp. 21375-21383
    • Gum Jr., J.R.1    Hicks, J.W.2    Toribara, N.W.3    Rothe, E.M.4    Lagace, R.E.5    Kim, Y.S.6
  • 53
    • 16244418685 scopus 로고    scopus 로고
    • Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium
    • Salamat-Miller N, Johnston TP. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. Int. J. Pharm. 294, 201-216 (2005
    • (2005) Int. J. Pharm , vol.294 , pp. 201-216
    • Salamat-Miller, N.1    Johnston, T.P.2
  • 54
    • 52149119477 scopus 로고    scopus 로고
    • Protein and peptide drug delivery: Oral approaches
    • Shaji J, Patole V. Protein and peptide drug delivery: oral approaches. Indian J. Pharm. Sci. 70(3), 269-277 (2008
    • (2008) Indian J. Pharm. Sci , vol.70 , Issue.3 , pp. 269-277
    • Shaji, J.1    Patole, V.2
  • 55
    • 0017701219 scopus 로고
    • Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol
    • Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252(11), 3578-3581 (1977
    • (1977) J. Biol. Chem , vol.252 , Issue.11 , pp. 3578-3581
    • Abuchowski, A.1    Van Es, T.2    Palczuk, N.C.3    Davis, F.F.4
  • 56
    • 0036379293 scopus 로고    scopus 로고
    • Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: The glucose stabilization effects of HIM2
    • Clement S, Still JG, Kosutic G, McAllister RG. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol. Ther. 4(4), 459-466 (2002
    • (2002) Diabetes Technol. Ther , vol.4 , Issue.4 , pp. 459-466
    • Clement, S.1    Still, J.G.2    Kosutic, G.3    McAllister, R.G.4
  • 57
    • 0036105205 scopus 로고    scopus 로고
    • Development of oral insulin: Progress and current status
    • Gordon Still J. Development of oral insulin: progress and current status. Diabetes Metab. Res. Rev. 18(Suppl. 1), S29-S37 (2002
    • (2002) Diabetes Metab. Res. Rev , vol.18 , Issue.SUPPL. 1
    • Gordon Still, J.1
  • 58
    • 0347316399 scopus 로고    scopus 로고
    • Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: Results from a Phase I/II clinical trial
    • Clement S, Dandona P, Still JG, Kosutic G. Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a Phase I/II clinical trial. Metabolism 53(1), 54-58 (2004
    • (2004) Metabolism , vol.53 , Issue.1 , pp. 54-58
    • Clement, S.1    Dandona, P.2    Still, J.G.3    Kosutic, G.4
  • 60
    • 77958084962 scopus 로고    scopus 로고
    • A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects
    • Khedkar A, Iyer H, Anand A et al. A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects. Diabetes Obes. Metab. 12(8), 659-664 (2010
    • (2010) Diabetes Obes. Metab , vol.12 , Issue.8 , pp. 659-664
    • Khedkar, A.1    Iyer, H.2    Anand, A.3
  • 61
  • 62
    • 71849101103 scopus 로고    scopus 로고
    • Alternative routes of administration for systemic delivery of protein pharmaceuticals
    • Moeller E, Jorgensen L. Alternative routes of administration for systemic delivery of protein pharmaceuticals. Drug Discov. Today Technol. 5(2-3), e89-e94 (2008
    • (2008) Drug Discov. Today Technol , vol.5 , Issue.2-3
    • Moeller, E.1    Jorgensen, L.2
  • 63
    • 85157044818 scopus 로고    scopus 로고
    • Formulation, stability and characterisation of protein and peptide drugs
    • Mahato R (Ed.). CRC Press, FL, USA
    • Frokjaer S. Formulation, stability and characterisation of protein and peptide drugs. In: Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids. Mahato R (Ed.). CRC Press, FL, USA (2005
    • (2005) Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids
    • Frokjaer, S.1
  • 64
    • 0032825974 scopus 로고    scopus 로고
    • Recent advances in buccal drug delivery and absorption - In vitro and in vivo studies
    • Junginger H. Recent advances in buccal drug delivery and absorption - in vitro and in vivo studies. J. Control. Release 62(1-2), 149-159 (1999
    • (1999) J. Control. Release , vol.62 , Issue.1-2 , pp. 149-159
    • Junginger, H.1
  • 65
    • 33746468534 scopus 로고    scopus 로고
    • Buccal bioadhesive drug delivery - A promising option for orally less efficient drugs
    • Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery - a promising option for orally less efficient drugs. J. Control. Release 114(1), 15-40 (2006
    • (2006) J. Control. Release , vol.114 , Issue.1 , pp. 15-40
    • Sudhakar, Y.1    Kuotsu, K.2    Bandyopadhyay, A.K.3
  • 67
    • 0003070827 scopus 로고    scopus 로고
    • Structure and function of the oral mucosa and implications for drug delivery
    • Rathborne M (Ed. Marcel-Dekker, Inc., NY, USA )
    • Squier C, Wertz P. Structure and function of the oral mucosa and implications for drug delivery. In: Oral Mucosal Drug Delivery. Rathborne M (Ed.). Marcel-Dekker, Inc., NY, USA (1996
    • (1996) Oral Mucosal Drug Delivery
    • Squier, C.1    Wertz, P.2
  • 68
    • 0035132416 scopus 로고    scopus 로고
    • Factors and strategies for improving buccal absorption of peptides
    • Veuillez F. Factors and strategies for improving buccal absorption of peptides. Eur. J. Pharm. Biopharm. 51(2), 93-109 (2001
    • (2001) Eur. J. Pharm. Biopharm , vol.51 , Issue.2 , pp. 93-109
    • Veuillez, F.1
  • 69
    • 79960086774 scopus 로고    scopus 로고
    • Advances in oral transmucosal drug delivery
    • Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J. Control. Release 53(2), 106-116 (2011
    • (2011) J. Control. Release , vol.53 , Issue.2 , pp. 106-116
    • Patel, V.F.1    Liu, F.2    Brown, M.B.3
  • 70
    • 0037148692 scopus 로고    scopus 로고
    • Peptidase activity on the surface of the porcine buccal mucosa
    • Walker G, Langoth N, Berknop-Schnurch A. Peptidase activity on the surface of the porcine buccal mucosa. Int. J. Pharm. 233(1-2), 141-147 (2002
    • (2002) Int. J. Pharm , vol.233 , Issue.1-2 , pp. 141-147
    • Walker, G.1    Langoth, N.2    Berknop-Schnurch, A.3
  • 71
    • 0032732323 scopus 로고    scopus 로고
    • Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets
    • Alur HH, Beal JD, Pather SI, Mitra AK, Johnston TP. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J. Pharm. Sci. 88(12), 1313-1319 (1999
    • (1999) J. Pharm. Sci , vol.88 , Issue.12 , pp. 1313-1319
    • Alur, H.H.1    Beal, J.D.2    Pather, S.I.3    Mitra, A.K.4    Johnston, T.P.5
  • 72
    • 0037712690 scopus 로고    scopus 로고
    • Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery
    • Remuñán-López C, Portero A, Vila-Jato JL, Alonso MJ. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J. Control. Release 55(2-3), 143-152 (1998
    • (1998) J. Control. Release , vol.55 , Issue.2-3 , pp. 143-152
    • Remuñán-López, C.1    Portero, A.2    Vila-Jato, J.L.3    Alonso, M.J.4
  • 73
    • 0033813758 scopus 로고    scopus 로고
    • Bioadhesive-based dosage forms: The next generation
    • Lee JW, Park JH, Robinson Jr. Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. 89(7), 850-866 (2000
    • (2000) J. Pharm. Sci , vol.89 , Issue.7 , pp. 850-866
    • Lee, J.W.1    Park, J.H.2    Robinson, J.R.3
  • 74
    • 34250891275 scopus 로고    scopus 로고
    • Mucoadhesive interactions of amphiphilic cationic copolymers based on [2-(methacryloyloxy) ethyl]trimethylammonium chloride
    • Fefelova NA, Nurkeeva ZS, Mun GA, Khutoryanskiy VV. Mucoadhesive interactions of amphiphilic cationic copolymers based on [2-(methacryloyloxy) ethyl]trimethylammonium chloride. Int. J. Pharm. 339(1-2), 25-32 (2007
    • (2007) Int. J. Pharm , vol.339 , Issue.1-2 , pp. 25-32
    • Fefelova, N.A.1    Nurkeeva, Z.S.2    Mun, G.A.3    Khutoryanskiy, V.V.4
  • 75
    • 0032507738 scopus 로고    scopus 로고
    • In vitro evaluation of the mucoadhesive properties of chitosan microspheres
    • He P, Davis S, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166(1), 75-88 (1998
    • (1998) Int. J. Pharm , vol.166 , Issue.1 , pp. 75-88
    • He, P.1    Davis, S.2    Illum, L.3
  • 76
    • 0033991816 scopus 로고    scopus 로고
    • Chitosan and its derivatives: Potential excipients for peroral peptide delivery systems
    • Bernkop-Schnürch A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int. J. Pharm. 194(1), 1-13 (2000
    • (2000) Int. J. Pharm , vol.194 , Issue.1 , pp. 1-13
    • Bernkop-Schnürch, A.1
  • 77
    • 0034734982 scopus 로고    scopus 로고
    • Lectin-mediated mucosal delivery of drugs and microparticles
    • Clark MA, Hirst BH, Jepson MA. Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Deliv. Rev. 43(2-3), 207-223 (2000
    • (2000) Adv. Drug Deliv. Rev , vol.43 , Issue.2-3 , pp. 207-223
    • Clark, M.A.1    Hirst, B.H.2    Jepson, M.A.3
  • 79
    • 78149339756 scopus 로고    scopus 로고
    • The buccal mucosa as an alternative route for the systemic delivery of risperidone
    • Heemstra LB, Finnin BC, Nicolazzo JA. The buccal mucosa as an alternative route for the systemic delivery of risperidone. J. Pharm. Sci. 99(11), 4584-4592 (2010
    • (2010) J. Pharm. Sci , vol.99 , Issue.11 , pp. 4584-4592
    • Heemstra, L.B.1    Finnin, B.C.2    Nicolazzo, J.A.3
  • 80
    • 77953618655 scopus 로고    scopus 로고
    • Nanoparticles for local drug delivery to the oral mucosa: Proof of principle studies
    • Holpuch AS, Hummel GJ, Tong M et al. Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharm. Res. 27(7), 1224-1236 (2010
    • (2010) Pharm. Res , vol.27 , Issue.7 , pp. 1224-1236
    • Holpuch, A.S.1    Hummel, G.J.2    Tong, M.3
  • 81
    • 84859436289 scopus 로고    scopus 로고
    • Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): A potential approach for buccal delivery of macromolecules
    • Giovino C, Ayensu I, Tetteh J, Boateng JS. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Int. J. Pharm. 428(1-2), 143-151 (2012
    • (2012) Int. J. Pharm , vol.428 , Issue.1-2 , pp. 143-151
    • Giovino, C.1    Ayensu, I.2    Tetteh, J.3    Boateng, J.S.4
  • 82
    • 20444371579 scopus 로고    scopus 로고
    • Buccal penetration enhancers - How do they really work?
    • Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers - how do they really work? J. Control. Release 105(1-2), 1-15 (2005
    • (2005) J. Control. Release , vol.105 , Issue.1-2 , pp. 1-15
    • Nicolazzo, J.A.1    Reed, B.L.2    Finnin, B.C.3
  • 83
    • 0029759228 scopus 로고    scopus 로고
    • In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs
    • Hoogstraate AJ, Coos Verhoef J, Pijpers A et al. In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm. Res. 13(8), 1233-1237 (1996
    • (1996) Pharm. Res , vol.13 , Issue.8 , pp. 1233-1237
    • Hoogstraate, A.J.1    Coos Verhoef, J.2    Pijpers, A.3
  • 84
    • 84864604538 scopus 로고    scopus 로고
    • Modeling the oral cavity: In vitro and in vivo evaluations of buccal drug delivery systems
    • Patel VF, Liu F, Brown MB. Modeling the oral cavity: in vitro and in vivo evaluations of buccal drug delivery systems. J. Control. Release 161(3), 746-756 (2012
    • (2012) J. Control. Release , vol.161 , Issue.3 , pp. 746-756
    • Patel, V.F.1    Liu, F.2    Brown, M.B.3
  • 85
    • 0037459005 scopus 로고    scopus 로고
    • Nasal drug delivery - Possibilities, problems and solutions
    • Illum L. Nasal drug delivery - possibilities, problems and solutions. J. Control. Release 87(1-3), 187-198 (2003
    • (2003) J. Control. Release , vol.87 , Issue.1-3 , pp. 187-198
    • Illum, L.1
  • 86
    • 0033229947 scopus 로고    scopus 로고
    • Delivery of peptide and non-peptide drugs through the respiratory tract
    • Davis S. Delivery of peptide and non-peptide drugs through the respiratory tract. Pharm. Sci. Technol. Today 2(11), 450-456 (1999
    • (1999) Pharm. Sci. Technol. Today , vol.2 , Issue.11 , pp. 450-456
    • Davis, S.1
  • 87
    • 0034095651 scopus 로고    scopus 로고
    • Transport of drugs from the nasal cavity to the central nervous system
    • Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci. 11, 1-18 (2000
    • (2000) Eur. J. Pharm. Sci , vol.11 , pp. 1-18
    • Illum, L.1
  • 89
    • 3542998669 scopus 로고    scopus 로고
    • Nasal route and drug delivery systems
    • Türker S, Onur E, Ozer Y. Nasal route and drug delivery systems. Pharm. World Sci. 26(3), 137-142 (2004
    • (2004) Pharm. World Sci , vol.26 , Issue.3 , pp. 137-142
    • Türker, S.1    Onur, E.2    Ozer, Y.3
  • 90
    • 68649090916 scopus 로고    scopus 로고
    • Nanoparticles for direct nose-to-brain delivery of drugs
    • Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int. J. Pharm. 379, 146-157 (2009
    • (2009) Int. J. Pharm , vol.379 , pp. 146-157
    • Mistry, A.1    Stolnik, S.2    Illum, L.3
  • 92
    • 70349556669 scopus 로고    scopus 로고
    • Nasal delivery of high molecular weight drugs
    • Ozsoy Y, Gungor S, Cevher E. Nasal delivery of high molecular weight drugs. Molecules 14, 3754-3779 (2009
    • (2009) Molecules , vol.14 , pp. 3754-3779
    • Ozsoy, Y.1    Gungor, S.2    Cevher, E.3
  • 93
    • 0025851808 scopus 로고
    • The nasal mucocilliary clearance: Relevance to nasal drug delivery
    • Schipper N, Verhoef J, Merkus F. The nasal mucocilliary clearance: relevance to nasal drug delivery. Pharm. Res. 8, 807-814 (1991
    • (1991) Pharm. Res , vol.8 , pp. 807-814
    • Schipper, N.1    Verhoef, J.2    Merkus, F.3
  • 94
    • 0001782792 scopus 로고    scopus 로고
    • Anatomy and physiology
    • Naclerio R, Durham S, Mygind N (Eds Marcel-Dekker, Inc., NY, USA
    • Baroody F. Anatomy and physiology. In: Rhinitis: Mechanisms and Management. Naclerio R, Durham S, Mygind N (Eds). Marcel-Dekker, Inc., NY, USA (1999
    • (1999) Rhinitis: Mechanisms and Management
    • Baroody, F.1
  • 95
    • 0002963196 scopus 로고    scopus 로고
    • Bioadhesive formulations for nasal peptide delivery
    • Mathiowitz E, Chickering D, Lehr CM (Eds Marcel- Dekker, Inc., NY, USA )
    • Illum L. Bioadhesive formulations for nasal peptide delivery In: Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches and Development. Mathiowitz E, Chickering D, Lehr CM (Eds). Marcel- Dekker, Inc., NY, USA (1999
    • (1999) Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches and Development
    • Illum, L.1
  • 98
    • 0026586445 scopus 로고
    • Drug metabolism in the nasal mucosa
    • Sarkar M. Drug metabolism in the nasal mucosa. Pharm. Res. 9, 1-9 (1992
    • (1992) Pharm. Res , vol.9 , pp. 1-9
    • Sarkar, M.1
  • 99
    • 33847073061 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route
    • Ding WX, Qi XR, Fu Q, Piao HS. Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route. Drug Deliv. 14(2), 101-104 (2007
    • (2007) Drug Deliv , vol.14 , Issue.2 , pp. 101-104
    • Ding, W.X.1    Qi, X.R.2    Fu, Q.3    Piao, H.S.4
  • 100
    • 30644471588 scopus 로고    scopus 로고
    • Nasal delivery of insulin using bioadhesive chitosan gels
    • Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv. 13(1), 31-38 (2006
    • (2006) Drug Deliv , vol.13 , Issue.1 , pp. 31-38
    • Varshosaz, J.1    Sadrai, H.2    Heidari, A.3
  • 101
    • 33744797668 scopus 로고    scopus 로고
    • Aminated gelatin microspheres as a nasal delivery system for peptide drugs: Evaluation of in vitro release and in vivo insulin absorption in rats
    • Wang J, Tabata Y, Morimoto K. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats. J. Control. Release 113(1), 31-37 (2006
    • (2006) J. Control. Release , vol.113 , Issue.1 , pp. 31-37
    • Wang, J.1    Tabata, Y.2    Morimoto, K.3
  • 102
    • 0026674499 scopus 로고
    • Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: Correlation with facilitated drug transport
    • Shao Z, Mitra AK. Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport. Pharm. Res. 9(9), 1184-1189 (1992
    • (1992) Pharm. Res , vol.9 , Issue.9 , pp. 1184-1189
    • Shao, Z.1    Mitra, A.K.2
  • 103
    • 0026663934 scopus 로고
    • Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning
    • Schipper N, Verhoef J, Romejin SG, Merkus F. Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning. J. Control. Release 21(1-3), 173-185 (1992
    • (1992) J. Control. Release , vol.21 , Issue.1-3 , pp. 173-185
    • Schipper, N.1    Verhoef, J.2    Romejin, S.G.3    Merkus, F.4
  • 104
    • 34447528700 scopus 로고    scopus 로고
    • Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery
    • Jain AK, Chalasani KB, Khar RK, Ahmed FJ, Diwan PV. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. J. Drug Target. 15(6), 417-427 (2007
    • (2007) J. Drug Target , vol.15 , Issue.6 , pp. 417-427
    • Jain, A.K.1    Chalasani, K.B.2    Khar, R.K.3    Ahmed, F.J.4    Diwan, P.V.5
  • 105
    • 0035189175 scopus 로고    scopus 로고
    • Enhancement of nasal absorption of calcitonin loaded in liposomes
    • Law SL, Huang KJ, Chou VH, Cherng JY. Enhancement of nasal absorption of calcitonin loaded in liposomes. J. Liposome Res. 11(2-3), 165-174 (2001
    • (2001) J. Liposome Res , vol.11 , Issue.2-3 , pp. 165-174
    • Law, S.L.1    Huang, K.J.2    Chou, V.H.3    Cherng, J.Y.4
  • 106
    • 0026520761 scopus 로고
    • Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats
    • Morimoto K, Iwakura Y, Nakatani E, Miyazaki M, Tojima H. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J. Pharm. Pharmacol. 44(3), 216-218 (1992
    • (1992) J. Pharm. Pharmacol , vol.44 , Issue.3 , pp. 216-218
    • Morimoto, K.1    Iwakura, Y.2    Nakatani, E.3    Miyazaki, M.4    Tojima, H.5
  • 107
    • 0025088495 scopus 로고
    • Nasal absorption enhancers for biosynthetic human growth hormone in rats
    • O'Hagan DT, Critchley H, Farraj NF et al. Nasal absorption enhancers for biosynthetic human growth hormone in rats. Pharm. Res. 7(7), 772-776 (1990
    • (1990) Pharm. Res , vol.7 , Issue.7 , pp. 772-776
    • O'Hagan, D.T.1    Critchley, H.2    Farraj, N.F.3
  • 108
    • 12344281758 scopus 로고    scopus 로고
    • Commercial challenges of protein drug delivery
    • Brown L. Commercial challenges of protein drug delivery. Expert Opin. Drug Del. 2(1), 29-42 (2005
    • (2005) Expert Opin. Drug Del , vol.2 , Issue.1 , pp. 29-42
    • Brown, L.1
  • 111
    • 84862109704 scopus 로고    scopus 로고
    • Noninvasive routes of proteins and peptides drug delivery
    • Jitendra, Sharma PK, Bansal S, Banik A. Noninvasive routes of proteins and peptides drug delivery. Indian J. Pharm. Sci. 73(4), 367-375 (2011
    • (2011) Indian J. Pharm. Sci , vol.73 , Issue.4 , pp. 367-375
    • Jitendra Sharma, P.K.1    Bansal, S.2    Banik, A.3
  • 112
    • 36849085410 scopus 로고    scopus 로고
    • Pfizer dumps Exubera
    • Mack GS. Pfizer dumps Exubera. Nat. Biotechnol. 25, 1331-1332 (2007
    • (2007) Nat. Biotechnol , vol.25 , pp. 1331-1332
    • Mack, G.S.1
  • 113
    • 67349152120 scopus 로고    scopus 로고
    • Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery
    • Chono S, Fukuchi R, Seki T, Morimoto K. Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. J. Control. Release 137(2), 104-109 (2009
    • (2009) J. Control. Release , vol.137 , Issue.2 , pp. 104-109
    • Chono, S.1    Fukuchi, R.2    Seki, T.3    Morimoto, K.4
  • 114
    • 0029055776 scopus 로고
    • Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors
    • Fukuda Y, Tsuji T, Fujita T, Yamamoto A, Muranishi S. Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors. Biol. Pharm. Bull. 18(6), 891-894 (1995
    • (1995) Biol. Pharm. Bull , vol.18 , Issue.6 , pp. 891-894
    • Fukuda, Y.1    Tsuji, T.2    Fujita, T.3    Yamamoto, A.4    Muranishi, S.5
  • 115
    • 0027955697 scopus 로고
    • Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats
    • Yamamoto A, Umemori S, Muranishi S. Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats. J. Pharm. Pharmacol. 46(1), 14-18 (1994
    • (1994) J. Pharm. Pharmacol , vol.46 , Issue.1 , pp. 14-18
    • Yamamoto, A.1    Umemori, S.2    Muranishi, S.3
  • 116
    • 84862327411 scopus 로고    scopus 로고
    • Enhanced pulmonary absorption of recombinant human insulin by pulmonary surfactant and phospholipid hexadecanol tyloxapol through Calu-3 monolayers
    • Zheng J, Zheng Y, Chen J et al. Enhanced pulmonary absorption of recombinant human insulin by pulmonary surfactant and phospholipid hexadecanol tyloxapol through Calu-3 monolayers. Pharmazie 67(5), 448-451 (2012
    • (2012) Pharmazie , vol.67 , Issue.5 , pp. 448-451
    • Zheng, J.1    Zheng, Y.2    Chen, J.3
  • 117
    • 77955903375 scopus 로고    scopus 로고
    • Technosphere® insulin: Defining the role of technosphere particles at the cellular level
    • Angelo R, Rousseau BS, Grant M, Leone-Bay A, Richardson P. Technosphere® insulin: defining the role of technosphere particles at the cellular level. J. Diabetes Sci. Technol. 3(3), 545-554 (2009
    • (2009) J. Diabetes Sci. Technol , vol.3 , Issue.3 , pp. 545-554
    • Angelo, R.1    Rousseau, B.S.2    Grant, M.3    Leone-Bay, A.4    Richardson, P.5
  • 120
    • 84868031494 scopus 로고    scopus 로고
    • Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus
    • Zisser H, Jovanovic L, Markova K et al. Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus. Diabetes Technol. Ther. 14(11), 997-1001 (2012
    • (2012) Diabetes Technol. Ther , vol.14 , Issue.11 , pp. 997-1001
    • Zisser, H.1    Jovanovic, L.2    Markova, K.3
  • 122
    • 84856597241 scopus 로고    scopus 로고
    • Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: Polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers
    • Murata M, Nakano K, Tahara K, Tozuka Y, Takeuchi H. Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers. Eur. J. Pharm. Biopharm. 80(2), 340-346 (2012
    • (2012) Eur. J. Pharm. Biopharm , vol.80 , Issue.2 , pp. 340-346
    • Murata, M.1    Nakano, K.2    Tahara, K.3    Tozuka, Y.4    Takeuchi, H.5
  • 123
    • 84869773544 scopus 로고    scopus 로고
    • Liposomal delivery of proteins and peptides
    • Swaminathan J, Ehrhardt C. Liposomal delivery of proteins and peptides. Expert Opin. Drug Deliv. 9(12) 1489-1503 (2012
    • (2012) Expert Opin. Drug Deliv , vol.9 , Issue.12 , pp. 1489-1503
    • Swaminathan, J.1    Ehrhardt, C.2
  • 124
    • 0025825296 scopus 로고
    • Degradation of insulin by trypsin and a-chymotrypsin
    • Schilling RJ, Mitra AK. Degradation of insulin by trypsin and a-chymotrypsin, Pharm. Res. 8, 721-727 (1991
    • (1991) Pharm. Res , vol.8 , pp. 721-727
    • Schilling, R.J.1    Mitra, A.K.2
  • 125
    • 0035901722 scopus 로고    scopus 로고
    • The effect of absorption enhancers on the initial degradation kinetics of insulin by alpha-chymotrypsin
    • Radwan MA, Aboul-Enein HY. The effect of absorption enhancers on the initial degradation kinetics of insulin by alpha-chymotrypsin. Int. J. Pharm. 217(1-2), 111-120 (2001
    • (2001) Int. J. Pharm , vol.217 , Issue.1-2 , pp. 111-120
    • Radwan, M.A.1    Aboul-Enein, H.Y.2
  • 126
    • 0029818353 scopus 로고    scopus 로고
    • Effects of enzyme inhibitors and insulin concentration on transepithelial transport of insulin in rats
    • Bai JP, Chang LL. Effects of enzyme inhibitors and insulin concentration on transepithelial transport of insulin in rats. J. Pharm. Pharmacol. 48(10), 1078-1082 (1996
    • (1996) J. Pharm. Pharmacol , vol.48 , Issue.10 , pp. 1078-1082
    • Bai, J.P.1    Chang, L.L.2
  • 127
    • 0019157951 scopus 로고
    • Cytotoxic effects of protease inhibitors on human cells part 2. Effect of Elastatinal
    • Yagi T, Ishizaki K, Takebe H. Cytotoxic effects of protease inhibitors on human cells part 2. Effect of Elastatinal. Cancer Lett. 10, 301-307 (1980
    • (1980) Cancer Lett , vol.10 , pp. 301-307
    • Yagi, T.1    Ishizaki, K.2    Takebe, H.3
  • 128
    • 0027534406 scopus 로고
    • Evidence for the role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6sialyltransferase from rat and mouse liver in whole-cell systems
    • McCaffrey G, Jamieson JC. Evidence for the role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6sialyltransferase from rat and mouse liver in whole-cell systems. Comp. Biochem. Physiol. B 104, 91-94 (1993
    • (1993) Comp. Biochem. Physiol. B , vol.104 , pp. 91-94
    • McCaffrey, G.1    Jamieson, J.C.2
  • 129
    • 0034306493 scopus 로고    scopus 로고
    • The scope and potential of vaginal drug delivery
    • Vermani K, Garg S. The scope and potential of vaginal drug delivery. Pharm. Sci. Technol. Today 3, 359-364 (2000
    • (2000) Pharm. Sci. Technol. Today , vol.3 , pp. 359-364
    • Vermani, K.1    Garg, S.2
  • 130
    • 26844560127 scopus 로고    scopus 로고
    • The use of mucoadhesive polymers in vaginal delivery
    • Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv. Drug Del. Rev. 57, 1692-1712 (2005
    • (2005) Adv. Drug Del. Rev , vol.57 , pp. 1692-1712
    • Valenta, C.1
  • 131
    • 0020416221 scopus 로고
    • Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: Absorption by various routes and absorption enhancement
    • Okada H, Yamazaki I, Ogawa Y, Hirai S, Yashiki T, Mima H. Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement. J. Pharm. Sci. 71(12), 1367-1371 (1982
    • (1982) J. Pharm. Sci , vol.71 , Issue.12 , pp. 1367-1371
    • Okada, H.1    Yamazaki, I.2    Ogawa, Y.3    Hirai, S.4    Yashiki, T.5    Mima, H.6
  • 132
    • 13144272288 scopus 로고    scopus 로고
    • Intravaginal drug delivery systems
    • Bernkop-Schnurch A, Hornof M. Intravaginal drug delivery systems. Am. J. Drug Deliv. 1(4), 241-254 (2003
    • (2003) Am. J. Drug Deliv , vol.1 , Issue.4 , pp. 241-254
    • Bernkop-Schnurch, A.1    Hornof, M.2
  • 133
    • 0035173648 scopus 로고    scopus 로고
    • Comparison of vaginal aminopeptidase enzymatic activities in various animals and in humans
    • Acartürk F, Parlatan Z, Saracoǧlu O. Comparison of vaginal aminopeptidase enzymatic activities in various animals and in humans. J. Pharm. Pharmacol. 53(11), 1499-1504 (2001
    • (2001) J. Pharm. Pharmacol , vol.53 , Issue.11 , pp. 1499-1504
    • Acartürk, F.1    Parlatan, Z.2    Saracoǧlu, O.3
  • 135
    • 0029552071 scopus 로고
    • Development of luteinizing hormone releasing hormone (LH-RH) delivery systems for vaginal mucosal route
    • Han K, Park JS, Chung YB, Jeong NJ, Park HB, Robinson Jr. Development of luteinizing hormone releasing hormone (LH-RH) delivery systems for vaginal mucosal route. Arch. Pharm. Res. 18, 325-331 (1995
    • (1995) Arch. Pharm. Res , vol.18 , pp. 325-331
    • Han, K.1    Park, J.S.2    Chung, Y.B.3    Jeong, N.J.4    Park, H.B.5    Robinson, J.R.6
  • 136
    • 0019975945 scopus 로고
    • Effective vaginal absorption of insulin in diabetic rats and rabbits using polyacrylic acid aqueous gel bases
    • Morimoto K, Takeeda T, Nakamoto Y, Morisaka K. Effective vaginal absorption of insulin in diabetic rats and rabbits using polyacrylic acid aqueous gel bases. Int. J. Pharm. 12, 107-111 (1982
    • (1982) Int. J. Pharm , vol.12 , pp. 107-111
    • Morimoto, K.1    Takeeda, T.2    Nakamoto, Y.3    Morisaka, K.4
  • 137
    • 27644512131 scopus 로고    scopus 로고
    • Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: Studies in rats
    • Ning M, Guo Y, Pan H, Yu H, Gu Z. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats. Drug Deliv. 12(6), 399-407 (2005
    • (2005) Drug Deliv , vol.12 , Issue.6 , pp. 399-407
    • Ning, M.1    Guo, Y.2    Pan, H.3    Yu, H.4    Gu, Z.5
  • 138
    • 79960306877 scopus 로고    scopus 로고
    • Niosomes: A controlled and novel drug delivery system
    • Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biol. Pharm. Bull. 34(7), 945-953 (2011
    • (2011) Biol. Pharm. Bull , vol.34 , Issue.7 , pp. 945-953
    • Rajera, R.1    Nagpal, K.2    Singh, S.K.3    Mishra, D.N.4
  • 139
    • 84867319576 scopus 로고    scopus 로고
    • Vaginal DNA vaccination against infectious diseases transmitted through the vagina
    • Kanazawa T, Takashima Y, Okada H. Vaginal DNA vaccination against infectious diseases transmitted through the vagina. Front. Biosci. (Elite Ed.) 4, 2340-2353 (2012
    • (2012) Front. Biosci. (Elite Ed) , vol.4 , pp. 2340-2353
    • Kanazawa, T.1    Takashima, Y.2    Okada, H.3
  • 140
    • 84860760141 scopus 로고    scopus 로고
    • Characterisation of protein stability in rod-insert vaginal rings
    • Pattani A, Lowry D, Curran RM et al. Characterisation of protein stability in rod-insert vaginal rings. Int. J. Pharm. 430(1-2), 89-97 (2012
    • (2012) Int. J. Pharm , vol.430 , Issue.1-2 , pp. 89-97
    • Pattani, A.1    Lowry, D.2    Curran, R.M.3
  • 141
    • 0342424651 scopus 로고
    • Systemic delivery of peptide-based pharmaceuticals
    • Marcel-Dekker, Inc., NY, USA
    • Chien, Y. Systemic delivery of peptide-based pharmaceuticals. In: Novel Drug Delivery Systems. Marcel-Dekker, Inc., NY, USA (1992
    • (1992) Novel Drug Delivery Systems
    • Chien, Y.1
  • 142
    • 0031563894 scopus 로고    scopus 로고
    • Peptide drug delivery: Colonic and rectal absorption
    • Mackay M, Philips J, Hastewell J. Peptide drug delivery: colonic and rectal absorption. Adv. Drug Deliv. 28, 253-273 (1997
    • (1997) Adv. Drug Deliv , vol.28 , pp. 253-273
    • Mackay, M.1    Philips, J.2    Hastewell, J.3
  • 144
    • 0032963526 scopus 로고    scopus 로고
    • Relative hypoglycemia of rectal insulin suppositories containing deoxycholic acid, sodium taurocholate, polycarbophil, and their combinations in diabetic rabbits
    • Hosny E. Relative hypoglycemia of rectal insulin suppositories containing deoxycholic acid, sodium taurocholate, polycarbophil, and their combinations in diabetic rabbits. Drug Dev. Ind. Pharm. 25(6), 745-752 (1999
    • (1999) Drug Dev. Ind. Pharm , vol.25 , Issue.6 , pp. 745-752
    • Hosny, E.1
  • 145
    • 0034752744 scopus 로고    scopus 로고
    • Effect of different bile salts on the relative hypoglycemia of witepsol W35 suppositories containing insulin in diabetic Beagle dogs
    • Hosny E, Al-Shora H, Elmazar M. Effect of different bile salts on the relative hypoglycemia of witepsol W35 suppositories containing insulin in diabetic Beagle dogs. Drug Dev. Ind. Pharm. 27(8), 837-845 (2001
    • (2001) Drug Dev. Ind. Pharm , vol.27 , Issue.8 , pp. 837-845
    • Hosny, E.1    Al-Shora, H.2    Elmazar, M.3
  • 146
    • 84867838466 scopus 로고    scopus 로고
    • Approaches for breaking the barriers of drug permeation through transdermal drug delivery
    • Alexander A, Dwivedi S, Ajazuddin et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J. Control. Release 164(1), 26-40 (2012
    • (2012) J. Control. Release , vol.164 , Issue.1 , pp. 26-40
    • Alexander, A.1    Ajazuddin, D.S.2
  • 147
    • 28044473874 scopus 로고    scopus 로고
    • Emerging strategies for the transdermal delivery of peptide and protein drugs
    • Schuetz YB, Naik A, Guy RH, Kalia YN. Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin. Drug Deliv. 2, 533-548 (2005
    • (2005) Expert Opin. Drug Deliv , vol.2 , pp. 533-548
    • Schuetz, Y.B.1    Naik, A.2    Guy, R.H.3    Kalia, Y.N.4
  • 148
    • 53549130424 scopus 로고    scopus 로고
    • Proteins and peptides: Strategies for delivery to and across the skin
    • Benson HA, Namjoshi S. Proteins and peptides: strategies for delivery to and across the skin. J. Pharm. Sci. 97(9), 3591-3610 (2008
    • (2008) J. Pharm. Sci , vol.97 , Issue.9 , pp. 3591-3610
    • Benson, H.A.1    Namjoshi, S.2
  • 149
    • 70349122971 scopus 로고    scopus 로고
    • Transdermal drug delivery: Evolving technologies and expanding opportunities
    • Aggarwal G, Garg A, Dhawan S. Transdermal drug delivery: evolving technologies and expanding opportunities. Indian J. Pharm. Ed. Res. 43, 251-259 (2009
    • (2009) Indian J. Pharm. Ed. Res , vol.43 , pp. 251-259
    • Aggarwal, G.1    Garg, A.2    Dhawan, S.3
  • 150
    • 73949137818 scopus 로고    scopus 로고
    • Penetration of nanoparticles and nanomaterials in the skin: Fiction or reality? J
    • Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J. Pharm. Sci. 99, 21-50 (2010
    • (2010) Pharm. Sci , vol.99 , pp. 21-50
    • Baroli, B.1
  • 151
    • 79955023808 scopus 로고    scopus 로고
    • Stratum corneum permeation and percutaneous drug delivery of hydrophilic molecules enhanced by cryopneumatic and photopneumatic technologies
    • Sun F, Anderson R, Aguilar G. Stratum corneum permeation and percutaneous drug delivery of hydrophilic molecules enhanced by cryopneumatic and photopneumatic technologies. J. Drugs Derm. 9, 1528-1530 (2010
    • (2010) J. Drugs Derm , vol.9 , pp. 1528-1530
    • Sun, F.1    Anderson, R.2    Aguilar, G.3
  • 152
    • 55049116362 scopus 로고    scopus 로고
    • Applications of ultrasonic skin permeation in transdermal drug delivery
    • Smith NB. Applications of ultrasonic skin permeation in transdermal drug delivery. Expert Opin. Drug Del. 5, 1107-1120 (2008
    • (2008) Expert Opin. Drug Del , vol.5 , pp. 1107-1120
    • Smith, N.B.1
  • 153
    • 78649956855 scopus 로고    scopus 로고
    • Low-frequency sonophoresis: Application to the transdermal delivery of macromolecules and hydrophilic drugs
    • Polat BE, Blankschtein D, Langer R. Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs. Expert Opin. Drug Del. 7, 1415-1432 (2010
    • (2010) Expert Opin. Drug Del , vol.7 , pp. 1415-1432
    • Polat, B.E.1    Blankschtein, D.2    Langer, R.3
  • 154
    • 0034902043 scopus 로고    scopus 로고
    • Novel mechanisms and devices to enable successful transdermal drug delivery
    • Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14, 101-114 (2001
    • (2001) Eur. J. Pharm. Sci , vol.14 , pp. 101-114
    • Barry, B.W.1
  • 155
    • 0037240324 scopus 로고    scopus 로고
    • Transdermal delivery of nalbuphine and its prodrugs by electroporation
    • Sung KC, Fang JY, Wang JJ, Hu OY. Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur. J. Pharm. Sci. 18, 63-70 (2003
    • (2003) Eur. J. Pharm. Sci , vol.18 , pp. 63-70
    • Sung, K.C.1    Fang, J.Y.2    Wang, J.J.3    Hu, O.Y.4
  • 157
    • 77951434882 scopus 로고    scopus 로고
    • Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety
    • Donnelly RF, Raj Singh TR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 17(4), 187-207 (2010
    • (2010) Drug Deliv , vol.17 , Issue.4 , pp. 187-207
    • Donnelly, R.F.1    Raj Singh, T.R.2    Woolfson, A.D.3
  • 158
    • 78651261187 scopus 로고    scopus 로고
    • Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique
    • Donnelly RF, Majithiya R, Singh TR et al. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm. Res. 28(1), 41-57 (2011
    • (2011) Pharm. Res , vol.28 , Issue.1 , pp. 41-57
    • Donnelly, R.F.1    Majithiya, R.2    Singh, T.R.3
  • 162
    • 0036007129 scopus 로고    scopus 로고
    • Macroflux microprojection array patch technology: A new and efficient approach for intracutaneous immunization
    • Matriano JA, Cormier M, Johnson J et al. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm. Res. 19(1), 63-70 (2002
    • (2002) Pharm. Res , vol.19 , Issue.1 , pp. 63-70
    • Matriano, J.A.1    Cormier, M.2    Johnson, J.3
  • 163
    • 3042556333 scopus 로고    scopus 로고
    • Transdermal delivery of desmopressin using a coated microneedle array patch system
    • Cormier M, Johnson B, Ameri M et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 97(3), 503-511 (2004
    • (2004) J. Control. Release , vol.97 , Issue.3 , pp. 503-511
    • Cormier, M.1    Johnson, B.2    Ameri, M.3
  • 164
    • 79952287383 scopus 로고    scopus 로고
    • Dissolving microneedle patch for transdermal delivery of human growth hormone
    • Lee JW, Choi SO, Felner EI, Prausnitz MR. Dissolving microneedle patch for transdermal delivery of human growth hormone. Small 7(4), 531-539 (2011
    • (2011) Small , vol.7 , Issue.4 , pp. 531-539
    • Lee, J.W.1    Choi, S.O.2    Felner, E.I.3    Prausnitz, M.R.4
  • 166
    • 84861963363 scopus 로고    scopus 로고
    • Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression
    • Pearton M, Saller V, Coulman SA et al. Microneedle delivery of plasmid DNA to living human skin: formulation coating, skin insertion and gene expression. J. Control. Release 160(3), 561-569 (2012
    • (2012) J. Control. Release , vol.160 , Issue.3 , pp. 561-569
    • Pearton, M.1    Saller, V.2    Coulman, S.A.3
  • 167
    • 84863490212 scopus 로고    scopus 로고
    • DNA vaccination in the skin using microneedles improves protection against inf luenza
    • Song JM, Kim YC, O E, Compans RW, Prausnitz MR, Kang SM. DNA vaccination in the skin using microneedles improves protection against inf luenza. Mol. Ther. 20(7), 1472-1480 (2012
    • (2012) Mol. Ther , vol.20 , Issue.7 , pp. 1472-1480
    • Song, J.M.1    Kim, Y.C.2    Compans, R.W.3    Prausnitz, M.R.4    Kang, S.M.5
  • 168
    • 84862629947 scopus 로고    scopus 로고
    • A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens
    • Matsuo K, Yokota Y, Zhai Y et al. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens. J. Control. Release 161(1), 10-17 (2012
    • (2012) J. Control. Release , vol.161 , Issue.1 , pp. 10-17
    • Matsuo, K.1    Yokota, Y.2    Zhai, Y.3
  • 169
    • 79960557083 scopus 로고    scopus 로고
    • Infusion pressure and pain during microneedle injection into skin of human subjects
    • 2011
    • Gupta J, Park SS, Bondy B, Felner EI, Prausnitz MR. Infusion pressure and pain during microneedle injection into skin of human subjects. Biomaterials 32(28), 6823-6231 (2011
    • Biomaterials , vol.32 , Issue.28 , pp. 6823-6231
    • Gupta, J.1    Park, S.S.2    Bondy, B.3    Felner, E.I.4    Prausnitz, M.R.5
  • 170
    • 79961173516 scopus 로고    scopus 로고
    • Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery
    • Migalska K, Morrow DI, Garland MJ, Thakur R, Woolfson AD, Donnelly RF. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm. Res. 28(8), 1919-1930 (2011
    • (2011) Pharm. Res , vol.28 , Issue.8 , pp. 1919-1930
    • Migalska, K.1    Morrow, D.I.2    Garland, M.J.3    Thakur, R.4    Woolfson, A.D.5    Donnelly, R.F.6
  • 171
    • 84870624248 scopus 로고    scopus 로고
    • Hydrogel forming microneedle arrays for enhanced transdermal drug delivery
    • Donnelly RF, Thakur RRS, Garland MJ et al. Hydrogel forming microneedle arrays for enhanced transdermal drug delivery. Adv. Funct. Mat. 22, 4879-4890 (2012
    • (2012) Adv. Funct. Mat , vol.22 , pp. 4879-4890
    • Donnelly, R.F.1    Rrs, T.2    Garland, M.J.3
  • 172
    • 41849128858 scopus 로고    scopus 로고
    • Electrically responsive smart hydrogels in drug delivery: A review
    • Kulkarni RV, Biswanath S. Electrically responsive smart hydrogels in drug delivery: a review. J. Appl. Biomater. Biomech. 5(3), 125-139 (2007
    • (2007) J. Appl. Biomater. Biomech , vol.5 , Issue.3 , pp. 125-139
    • Kulkarni, R.V.1    Biswanath, S.2
  • 175
    • 85157052609 scopus 로고    scopus 로고
    • Frost Sullivan Accessed on 8 January 2013
    • Frost, Sullivan. Merrion pharmaceuticals (2008). www.merrionpharma.com/ archive/FandS-MP-051108.pdf (Accessed on 8 January 2013
    • (2008) Merrion Pharmaceuticals


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.